Toxicant exposure and bioaccumulation: A common and potentially reversible cause of cognitive dysfunction and dementia

Behavioural Neurology

Volumn 2015, Issue , 2015, Pages

  Genuis, Stephen J ^a   Kelln, Kasie L ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CREATININE; EDETIC ACID; FERRITIN; IMMUNOGLOBULIN E; LEAD; LITHIUM; MOOD STABILIZER; QUETIAPINE; SUCCIMER; VALPROATE SEMISODIUM;

AGED; BIOACCUMULATION; BIPOLAR DISORDER; CASE REPORT; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEMENTIA; DEPRESSION; DIET SUPPLEMENTATION; ENVIRONMENTAL EXPOSURE; FATIGUE; FERRITIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MANIA; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; POLLUTANT; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; REVIEW; SOCIAL ISOLATION; TOENAIL ONYCHOMYCOSIS; ADVERSE EFFECTS; CHEMICALLY INDUCED; COGNITION DISORDERS; MENTAL DISEASE; MERCURIALISM; PATHOPHYSIOLOGY;

AGED; COGNITION DISORDERS; DEMENTIA; ENVIRONMENTAL EXPOSURE; HUMANS; MALE; MENTAL DISORDERS; MERCURY POISONING;

EID: 84924025086     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.1155/2015/620143     Document Type: Review

References (107)

1. "Alzheimer's incidence accelerates among the oldest old," in Proceedings of the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD '09), vienna, Austria, 2009, http://www.medpagetoday.com/MeetingCoverage/ICAD/15075.
2. 2014 Alzheimer's Disease Facts and Figures, Alzheimer's Association, 2014.
3. J. Weuve, L. E. Hebert, P. A. Scherr, and D. A. Evans, "Deaths in the United States among persons with Alzheimer's disease (2010-2050)," Alzheimer's & Dementia, vol. 10, no. 2, pp. e40- e46, 2014.
4. M. P. J. M. Dijkers, "The value of 'traditional' reviews in the era of systematic reviewing," The American Journal of Physical Medicine and Rehabilitation, vol. 88, no. 5, pp. 423-430, 2009.
5. M. T. Baltazar, R. J. Dinis-Oliveira, M. D. L. Bastos, A. M. Tsatsakis, J. A. Duarte, and F. Carvalho, "Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-a mechanistic approach," Toxicology Letters, vol. 230, pp. 85-103, 2014.
6. L. Mah, "Efficacy and safety of the anti-PD-1 monoclonal antibodyMK-3475 in 411 patients (pts) with melanoma (MEL)," Journal of Clinical Oncology, vol. 32, no. 5, supplement, 2014, 2014 ASCO Annual Meeting, Abstract no. LBA9000.
7. J. R. Cannon and J. T. Greenamyre, "The role of environmental exposures in neurodegeneration and neurodegenerative diseases," Toxicological Sciences, vol. 124, no. 2, pp. 225-250, 2011.
8. P. Schofield, "Dementia associated with toxic causes and autoimmune disease," International Psychogeriatrics, vol. 17, no. 1, pp. S129-S147, 2005.
9. R. Visvanathan, "Is it truly dementia?" The Lancet, vol. 357, no. 9257, article 684, 2001.
10. J. Richardson, A. Roy, S. Shalat et al., "Elevated serumpesticide levels and risk for Alzheimer disease," Journal of American Medical Association Neurology, vol. 71, pp. E1-E7, 2014.
11. Dichlorodiphenyltrichloroethane (DDT): Centers for Disease Control and Prevention, 2009.
12. Pesticide Monitoring Program-FY 2008, Food and Drug Administration, 2008.
13. J. Lu, J. Miao, T. Su, Y. Liu, and R. He, "Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo," Biochimica et Biophysica Acta (BBA)- General Subjects, vol. 1830, no. 8, pp. 4102-4116, 2013.
14. Y. Lu, H. J. He, J. Zhou et al., "Hyperphosphorylation results in tau dysfunction in DNA folding and protection," Journal of Alzheimer's Disease, vol. 37, no. 3, pp. 551-563, 2013.
15. J. D. Rizak, Y. Ma, and X. Hu, "Is formaldehyde the missing link in AD pathology? The differential aggregation of amyloid-beta with APOE isoforms in vitro," Current Alzheimer Research, vol. 11, no. 5, pp. 461-468, 2014.
16. M. Yang, J. Lu, J. Miao et al., "Alzheimer's disease and methanol toxicity (part 1): chronic methanol feeding led to memory impairments and tau hyperphosphorylation in mice," Journal of Alzheimer's disease, vol. 41, no. 4, pp. 1117-1129, 2014.
17. M. Yang, J. Miao, J. Rizak et al., "Alzheimer's disease and methanol toxicity (part 2): lessons from four rhesus macaques (Macaca mulatta) chronically fed methanol," Journal of Alzheimer's Disease, vol. 41, no. 4, pp. 1131-1147, 2014.
18. S. Billioti de Gage, B. Begaud, F. Bazin et al., "Benzodiazepine use and risk of dementia: prospective population based study," British Medical Journal, vol. 349, Article IDe6231, 2014.
19. N. M. Gatto, V.W. Henderson, H. N. Hodis et al., "Components of air pollution and cognitive function in middle-aged and older adults in Los Angeles," NeuroToxicology, vol. 40, pp. 1-7, 2014.
20. F. Al-Mousa and F. Michelangeli, "Some commonly used brominated flame retardants cause Ca2+-atpase inhibition, betaamyloid peptide release and apoptosis in SH-SY5Y neuronal cells," PLoS ONE, vol. 7, no. 4,Article ID e33059, 2012.
21. C. F. Jin, M. Haut, and A. Ducatman, "Industrial solvents and psychological effects," Clinics in Occupational and Environmental Medicine, vol. 4, no. 4, pp. 597-620, 2004.
22. E. Mariussen, "Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance," Archives of Toxicology, vol. 86, no. 9, pp. 1349-1367, 2012.
23. H. A. Tilson, P. Rao, and S. Kodavanti, "The neurotoxicity of polychlorinated biphenyls,"NeuroToxicology, vol. 19,no. 4-5, pp. 517-525, 1998.
24. H.-A. Rother, "Communicating pesticide neurotoxicity research findings and risks to decision-makers and the public," NeuroToxicology, vol. 45, pp. 327-337, 2014.
25. K.-S. Liu, J.-H. Hao, Y. Zeng, F.-C. Dai, and P.-Q. Gu, "Neurotoxicity and biomarkers of lead exposure: a review," Chinese Medical Sciences Journal, vol. 28, no. 3, pp. 178-188, 2013.
26. B. Walker Jr., "Neurotoxicity in human beings," Journal of Laboratory and Clinical Medicine, vol. 136, no. 3, pp. 168-180, 2000.
27. D. O. Carpenter and R. Nevin, "Environmental causes of violence," Physiology & Behavior, vol. 99, no. 2, pp. 260-268, 2010.
28. S. C. Bondy, "Prolonged exposure to low levels of aluminum leads to changes associated with brain aging and neurodegeneration," Toxicology, vol. 315, no. 1, pp. 1-7, 2014.
29. R. Lucchini and N. Zimmerman, "Lifetime cumulative exposure as a threat for neurodegeneration: need for prevention strategies on a global scale," NeuroToxicology, vol. 30, no. 6, pp. 1144-1148, 2009.
30. K. J. Barnham and A. I. Bush, "Biological metals and metaltargeting compounds in major neurodegenerative diseases," Chemical Society Reviews, vol. 43, no. 19, pp. 6727-6749, 2014.
31. G. J. Brewer, "Alzheimer's disease causation by copper toxicity and treatment with zinc," Frontiers in Aging Neuroscience, vol. 6, article 92, 2014.
32. R. Squitti, "Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of nonceruloplasmim copper in mild cognitive impairment conversion to full AD," Journal of Trace Elements in Medicine and Biology, vol. 28, no. 4, pp. 482-485, 2014.
33. R. Squitti, M. Siotto, and R. Polimanti, "Low-copper diet as a preventive strategy for Alzheimer's disease," Neurobiology of Aging, vol. 35, supplement 2, pp. S40-S50, 2014.
34. C. Exley and T. vickers, "Elevated brain aluminium and early onset Alzheimer's disease in an individual occupationally exposed to aluminium: a case report," Journal of Medical Case Reports, vol. 8, no. 1, article 41, 2014.
35. E. van Wijngaarden, J. R. Campbell, and D. A. Cory-Slechta, "Bone lead levels are associated with measures of memory impairment in older adults," NeuroToxicology, vol. 30, no. 4, pp. 572-580, 2009.
36. C. Patterson, J. W. Feightner, A. Garcia, G.-Y. R. Hsiung, C. MacKnight, and A. D. Sadovnick, "Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease," Canadian Medical Association Journal, vol. 178, no. 5, pp. 548-556, 2008.
37. M. L. Bleecker, D. P. Ford, K. N. Lindgren, V. M. Hoese, K. S. Walsh, and C. G. vaughan, "Differential affects of lead exposure on components of verbal memory," Occupational and Environmental Medicine, vol. 62, no. 3, pp. 181-187, 2005.
38. W. F. Stewart and B. S. Schwartz, "Effects of lead on the adult brain: a 15-year exploration,"TheAmerican Journal of Industrial Medicine, vol. 50, no. 10, pp. 729-739, 2007.
39. Centers for Disease Control and Prevention: Department of Health and Human Services, Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, Centers for Disease Control and Prevention: Department of Health and Human Services, Atlanta, Ga, USA, 2013, http://www.cdc.gov/exposurereport/pdf/FourthReport UpdatedTables Mar2013.pdf.
40. Health Canada, "Second report on human biomonitoring of environmental chemicals in Canada," 2013, http://occupationalcancer. ca/wp-content/uploads/2013/05/2ndHumanBiomonitoringReport. pdf.
41. Environmental Working Group, "Toxic Chemicals Found In Minority Cord Blood," 2009, http://www.ewg.org/news/newsreleases/2009/12/02/toxic-chemicals-found-minority-cord-blood.
42. D. A. Rossignol, S. J. Genuis, and R. E. Frye, "Environmental toxicants and autism spectrum disorders: a systematic review," Translational Psychiatry, vol. 4, articel e360, 2014.
43. P. Grandjean and P. Landrigan, "Developmental neurotoxicity of industrial chemicals," The Lancet, vol. 368, no. 9553, pp. 2167-2178, 2006.
44. P. Grandjean and P. J. Landrigan, "Neurobehavioural effects of developmental toxicity," The Lancet Neurology, vol. 13, no. 3, pp. 330-338, 2014.
45. D. Coury, "Pediatric Academic societies annual meeting. April 28-May 1, 2001. Baltimore,Maryland, USA. Abstracts," Pediatric Research, vol. 49, no. 4, part 2, supplement, 2001.
46. A. Kanthasamy, H. Jin, V. Anantharam et al., "Emerging neurotoxic mechanisms in environmental factors-induced neurodegeneration," NeuroToxicology, vol. 33, no. 4, pp. 833-837, 2012.
47. M. L. Block, A. Elder, R. L. Auten et al., "The outdoor air pollution and brain health workshop," NeuroToxicology, vol. 33, no. 5, pp. 972-984, 2012.
48. J. Reis and G. C. Román, "Environmental neurology: a promising new field of practice and research," Journal of the Neurological Sciences, vol. 262, no. 1-2, pp. 3-6, 2007.
49. E. L. Sabbath, L.-A. Gutierrez, C. A. Okechukwu et al., "Time may not fully attenuate solvent-associated cognitive deficits in highly exposed workers," Neurology, vol. 82, no. 19, pp. 1716-1723, 2014.
50. S. J. Genuis,M. E. Sears,G. Schwalfenberg, J. Hope, and R. Bernhoft, "Clinical detoxification: elimination of persistent toxicants from the human body," The Scientific World Journal, vol. 2013, Article ID 238347, 3 pages, 2013.
51. J. Hope, "A review of the mechanism of injury and treatment approaches for illness resulting from exposure to waterdamaged buildings,mold, andmycotoxins,"TheScientificWorld Journal, vol. 2013, Article ID 767482, 20 pages, 2013.
52. Drugs.com, "Levonorgestrel and ethinyl estradiol. TABLE I: Mean (SD) Pharmacokinetic parameters of Levonorgestrel and Ethinyl Estradiol tablets over a 21-day dosing period," 2014, http://www.drugs.com/pro/levonorgestrel-and-ethinyl-estradiol. html.
53. W. V. Welshons, K. A. Thayer, B. M. Judy, J. A. Taylor, E. M. Curran, and F. S. vom Saal, "Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity," EnvironmentalHealth Perspectives, vol. 111, no. 8, pp. 994-1006, 2003.
54. K. Steenland, S. Tinker, A. Shankar, and A. Ducatman, "Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA," Environmental Health Perspectives, vol. 118, no. 2, pp. 229-233, 2010.
55. S. J. Frisbee, A. Shankar, S. S. Knox et al., "Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 health project," Archives of Pediatrics and AdolescentMedicine, vol. 164, no. 9, pp. 860-869, 2010.
56. E. A. Belyaeva, T. V. Sokolova, L. V. Emelyanova, and I. O. Zakharova, "Mitochondrial electron transport chain in heavy metal-induced neurotoxicity: effects of cadmium, mercury, and copper," The Scientific World Journal, vol. 2012, Article ID 136063, 14 pages, 2012.
57. Y.W. Chen, C. F. Huang, C. Y. Yang, C. C. Yen, K. S. Tsai, and S. H. Liu, "Inorganic mercury causes pancreatic β-cell death via the oxidative stress-induced apoptotic and necrotic pathways," Toxicology and Applied Pharmacology, vol. 243, no. 3, pp. 323-331, 2010.
58. Q. Huang, J. Zhang, F. L. Martin et al., "Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study," Toxicology Letters, vol. 223, no. 2, pp. 211-220, 2013.
59. B. Weiss, "The intersection of neurotoxicology and endocrine disruption," NeuroToxicology, vol. 33, no. 6, pp. 1410-1419, 2012.
60. C. Guerrero-Bosagna and M. K. Skinner, "Environmentally induced epigenetic transgenerational inheritance of phenotype and disease,"Molecular and Cellular Endocrinology, vol. 354, no. 1-2, pp. 3-8, 2012.
61. S. Orrenius, P. Nicotera, and B. Zhivotovsky, "Cell death mechanisms and their implications in toxicology," Toxicological Sciences, vol. 119, no. 1, pp. 3-19, 2011.
62. G. S. Bloom, "Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis," JAMA Neurology, vol. 71, no. 4, pp. 505-508, 2014.
63. S. M. Lasley and M. E. Gilbert, "Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chronic lead exposure level," Toxicological Sciences, vol. 66, no. 1, pp. 139-147, 2002.
64. L. S. Kjeldsen, M. Ghisari, and E. C. Bonefeld-Jørgensen, "Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity," Toxicology and Applied Pharmacology, vol. 272, no. 2, pp. 453-464, 2013.
65. S. J. Genuis, "The chemical erosion of human health: adverse environmental exposure and in-utero pollution-determinants of congenital disorders and chronic disease," Journal of Perinatal Medicine, vol. 34, no. 3, pp. 185-195, 2006.
66. S. J. Genuis, M. E. Sears, G. Schwalfenberg, J. Hope, and R. Bernhoft, "Clinical detoxification: elimination of persistent toxicants from the human body," The Scientific World Journal, vol. 2013, Article ID 238347, 3 pages, 2013.
67. T. G. Redgrave, P. Wallace, R. J. Jandacek, and P. Tso, "Treatment with a dietary fat substitute decreased Arochlor 1254 contamination in an obese diabetic male," The Journal of Nutritional Biochemistry, vol. 16, no. 6, pp. 383-384, 2005.
68. G. H. Ross and M. C. Sternquist, "Methamphetamine exposure and chronic illness in police officers: significant improvement with sauna-based detoxification therapy," Toxicology and Industrial Health, vol. 28, no. 8, pp. 758-768, 2012.
69. R. J. Jandacek, J. E. Heubi, D. D. Buckley et al., "Reduction of the body burden of PCBs and DDE by dietary intervention in a randomized trial," Journal of Nutritional Biochemistry, vol. 25, no. 4, pp. 483-488, 2014.
70. S. J. Genuis, D. Birkholz, I. Rodushkin, and S. Beesoon, "Blood, urine, and sweat (BUS) study: monitoring and elimination of bioaccumulated toxic elements," Archives of Environmental Contamination & Toxicology, vol. 61, no. 2, pp. 344-357, 2011.
71. R. J. Jandacek and S. J. Genuis, "An assessment of the intestinal lumen as a site for intervention in reducing body burdens of organochlorine compounds," The Scientific World Journal, vol. 2013, Article ID205621, 10 pages, 2013.
72. P. A. Egner, J. G. Chen, A. T. Zarth et al., "Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China," Cancer Prevention Research, vol. 7, no. 8, pp. 813-823, 2014.
73. S. J. Genuis, "Elimination of persistent toxicants from the human body," Human and Experimental Toxicology, vol. 30, no. 1, pp. 3-18, 2011.
74. S. J. Genuis, Y. Liu, Q. I. T. Genuis, J.W. Martin, and T. Kanda, "Phlebotomy treatment for elimination of perfluoroalkyl acids in a highly exposed family: a retrospective case-series," PLoS ONE, vol. 9, no. 12, Article IDe114295, 2014.
75. S. J. Genuis, "Toxic causes of mental illness are overlooked," NeuroToxicology, vol. 29, no. 6, pp. 1147-1149, 2008.
76. J. B. Adams, M. Baral, E. Geis et al., "Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A-medical results," BMC Clinical Pharmacology, vol. 9, article 16, 2009.
77. J. B. Adams, M. Baral, E. Geis et al., "Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B-behavioral results," BMC Clinical Pharmacology, vol. 9, article 1472, 2009.
78. D. E. Bredesen, "Reversal of cognitive decline: a novel therapeutic program," Aging, vol. 6, no. 9, pp. 707-717, 2014.
79. S. Porru and L. Alessio, "The use of chelating agents in occupational lead poisoning," Occupational Medicine, vol. 46, no. 1, pp. 41-48, 1996.
80. S. Bradberry, T. Sheehan, and A. vale, "Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning," QJM: An International Journal ofMedicine, vol. 102, no. 10, pp. 721-732, 2009.
81. S. Bradberry and A. vale, "Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning," Clinical Toxicology, vol. 47, no. 7, pp. 617-631, 2009.
82. M. E. Sears, "Chelation: harnessing and enhancing heavy metal detoxification-a review,"TheScientificWorld Journal, vol. 2013, Article ID 219840, 13 pages, 2013.
83. R. P. Wedeen, "Lead poisoning: the evolving definition," International Journal of Occupational and Environmental Medicine, vol. 2, no. 1, pp. 1-3, 2011.
84. S. Hernberg, "Lead poisoning in a historical perspective," American Journal of IndustrialMedicine, vol. 38, no. 3, pp. 244-254, 2000.
85. W. N. Arnold, "The illness of vincent van Gogh," Journal of the History of the Neurosciences, vol. 13, no. 1, pp. 22-43, 2004.
86. R. J. Shamberger, "validity of hair mineral testing," Biological Trace Element Research, vol. 87, no. 1-3, pp. 1-28, 2002.
87. Centers for Disease Control and Prevention (CDC), "very high blood lead levels among adults-United States, 2002-2011," Morbidity & Mortality Weekly Report, vol. 62, no. 47, pp. 967-971, 2002.
88. J. Liu and G. Lewis, "Environmental toxicity and poor cognitive outcomes in children and adults," Journal of Environmental Health, vol. 76, no. 6, pp. 130-138, 2014.
89. L. Mah, M. Kohli, and G. Chan, "Ambient lead exposure is associated with greater risk of conversion to Alzheimer's disease and hippocampal atrophy in individuals with amnestic mild cognitive impairment," The American Journal of Geriatric Psychiatry, vol. 22, no. 3, pp. S117-S118, 2014.
90. Centers for Disease Control and Prevention (CDC), "Lead exposure among females of childbearing age-United States, 2004," Morbidity & Mortality Weekly Report, vol. 56, no. 16, pp. 397-400, 2007.
91. S. J. Genuis, G. Schwalfenberg, A.-K. J. Siy, and I. Rodushkin, "Toxic element contamination of natural health products and pharmaceutical preparations," PLoS ONE, vol. 7, no. 11, Article ID e49676, 2012.
92. H. Needleman, "Lowlevel lead exposure: history and discovery," Annals of Epidemiology, vol. 19, no. 4, pp. 235-238, 2009.
93. M. Casas, C. Chevrier, E. D. Hond et al., "Exposure to brominated flame retardants, perfluorinated compounds, phthalates and phenols in European birth cohorts: ENRIECO evaluation, first human biomonitoring results, and recommendations," International Journal of Hygiene and Environmental Health, vol. 216, no. 3, pp. 230-242, 2013.
94. S. L. Archibeque-Engle, J. D. Tessari, D. T. Winn, T. J. Keefe, T. M. Nett, and T. Zheng, "Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum," Journal of Toxicology and Environmental Health, vol. 52, no. 4, pp. 285-293, 1997.
95. G.W. Yu, J. Laseter, and C. Mylander, "Persistent organic pollutants in serum and several different fat compartments in humans," Journal of Environmental and Public Health, vol. 2011, Article ID 417980, 8 pages, 2011.
96. R. J. Jandacek, N. Anderson, M. Liu, S. Zheng, Q. Yang, and P. Tso, "Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 288, no. 2, pp. G292-G299, 2005.
97. S. M. Rappaport and M. T. Smith, "Environment and disease risks," Science, vol. 330, no. 6003, pp. 460-461, 2010.
98. S. J. Genuis, "Medical practice and community health care in the 21st century: a time of change," Public Health, vol. 122, no. 7, pp. 671-680, 2008.
99. J. R. Roberts and J. R. Reigart, "Environmental health education in the medical school curriculum," Ambulatory Pediatrics, vol. 1, no. 2, pp. 108-111, 2001.
100. K. S. Gehle, J. L. Crawford, and M. T. Hatcher, "Integrating environmental health into medical education," American Journal of Preventive Medicine, vol. 41, no. 4, pp. S296-S301, 2011.
101. K. H. Kilburn, "Why is chemical brain injury ignored? Pondering causes and risks," Archives of Environmental Health, vol. 58, no. 3, pp. 132-134, 2003.
102. S. J. Genuis, "Back to the future of healthcare: aetiology-centred medicine," The New Zealand Medical Journal, vol. 118, no. 1215, Article ID U1467, 2005.
103. S. J. Genuis, "What's out there making us sick?" Journal of Environmental and Public Health, vol. 2012, Article ID 605137, 10 pages, 2012.
104. D. Rhodes, A. Spiro III, A. Aro, and H. Hu, "Relationship of bone and blood lead levels to psychiatric symptoms: the normative aging study," Journal of Occupational and Environmental Medicine, vol. 45, no. 11, pp. 1144-1151, 2003.
105. H. S. Hendriks, E. C. Antunes Fernandes, å. Bergman, M. van den Berg, and R. H. S. Westerink, "PCB-47, PBDE-47, and 6-OH-PBDE-47 differentially modulate human GABAA and alpha4beta2 nicotinic acetylcholine receptors," Toxicological Sciences, vol. 118, no. 2, pp. 635-642, 2010.
106. S. M. Goldman, P. J. Quinlan, G.W. Ross et al., "Solvent exposures and Parkinson disease risk in twins," Annals of Neurology, vol. 71, no. 6, pp. 776-784, 2012.
107. V. Jevtovic-Todorovic, A. R. Absalom, K. Blomgren et al., "Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar," British Journal of Anaesthesia, vol. 111, no. 2, pp. 143-151, 2013.